Pharm Exec6h
FDA Grants Priority Review to Merck’s Welireg for Advanced, Unresectable, or Metastatic Pheochromocytoma, Paraganglioma
Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in ...
Pharm Exec6h
EMA Takes Break From X, Joins Bluesky
The government agency says X no longer suits its communication needs.
Pharm Exec8h
FDA Approves Supplemental Biologics License Application for Intravenous Maintenance Dosing of Leqembi in Alzheimer Disease
Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with ...
Pharm Exec12h
Exploring Biopharma's Dealmaking Terrain, Roadmap in China
A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.
Pharm Exec11h
Preeclampsia Foundation Launches GAP—SPIRIN
Campaign encourages the use of low-dose aspirin to help reduce the risk of preeclampsia and the complications that come with ...
Pharm Exec15h
Unifying Commercial Teams for Customer-Centric HCP Engagement: Q&A with Matt Farrell
Veeva’s vice president of commercial strategy discusses how streamlining their processes with a single goal in mind can ...